Brief: Paradigm Health Collaborates With FDA To Transform Regulatory Review Of Clinical Trial Data
28/04/2026 18:48
April 28 (Reuters) - Paradigm Health: PARADIGM HEALTH ANNOUNCES COLLABORATION WITH THE FDA TO TRANSFORM REGULATORY REVIEW OF CLINICAL TRIAL DATA PARADIGM HEALTH: AMGEN & ASTRAZENECA FIRST TO JOIN THIS COLLABORATION ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amgen
See all newsFactbox: Global drugmakers invest billions to boost US presence
China's Harbour BioMed to focus on another patent case after $20 million damages award
Amgen owes $20.2 million in antibody patent lawsuit, US jury says (updated)
Amgen owes $20.2 mln in antibody patent lawsuit, US jury says
Amgen taps research firm to reassess Tavneos data (updated)